Reserpine (Reserpine) - Summary

RESERPINE SUMMARY

Reserpine Tablets, USP

Reserpine, USP is an antihypertensive, available as 0.1 mg and 0.25 mg tablets for oral administration.

Reserpine is indicated for the following:

Mild essential hypertension; also useful as adjunctive therapy with other antihypertensive agents in the more severe forms of hypertension; relief of symptoms in agitated psychotic states (e.g., schizophrenia), primarily in those individuals unable to tolerate phenothiazine derivatives or in those who also require antihypertensive medication.

RESERPINE NEWS HIGHLIGHTS

Published Studies Related to Reserpine

A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. [2005.03]

A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension. [1997.12]

Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor. [1997.09]

Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group. [1997.02]

Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP). [1995.12]

more>>

Clinical Trials Related to Reserpine

Reserpine for the Treatment of Cocaine Dependence - 1 [Active, not recruiting]

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 [Active, not recruiting]

Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) [Completed]

Systolic Hypertension in the Elderly Program (SHEP) [Completed]

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]

more>>